Vigil Neuroscience Inc (VIGL)
3.52
-0.02
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
3.52
0.00 (0.00%)
After-Hours: 20:00
Vigil Neuroscience Total Liabilities (Quarterly): 21.30M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.30M |
| December 31, 2023 | 24.61M |
| September 30, 2023 | 23.32M |
| June 30, 2023 | 21.57M |
| March 31, 2023 | 21.02M |
| December 31, 2022 | 11.31M |
| Date | Value |
|---|---|
| September 30, 2022 | 9.597M |
| June 30, 2022 | 7.302M |
| March 31, 2022 | 6.634M |
| December 31, 2021 | 171.88M |
| September 30, 2021 | 171.67M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.634M
Minimum
Mar 2022
171.88M
Maximum
Dec 2021
44.57M
Average
21.30M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| TG Therapeutics Inc | 213.21M |
| Terns Pharmaceuticals Inc | 10.05M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.08M |
| Shareholders Equity (Quarterly) | 103.78M |